ANTIVIRAL:
CLOUDBREAK® AVCs

Cidara is developing a new generation of immunotherapeutic antivirals from its Cloudbreak platform that couple potent antivirals to a human antibody fragment. These long-acting, antiviral conjugates (AVCs) directly inhibit viral proliferation while simultaneously engaging the immune system to maximize viral clearance.

Overview

Influenza

HIV, RSV, SARS-CoV-2
And Other Viruses

AVCs have the potential to treat and prevent other life-threatening viruses, including RSV, HIV and SARS-CoV-2. Preclinical and discovery efforts are ongoing.

Subscribe here for updates.